Silas Buck, PhD, first fell in love with neuroscience during the earliest days of his undergraduate career, when he became fascinated with the complex biological reactions that were responsible for even his earliest lab experiments. Buck pursued this passion through graduate school, studying how dopamine neurons become vulnerable to degeneration in Parkinson’s disease.
This October, members of the Duke Neurology Department contributed to 11 new peer-reviewed journal articles, advancing the fields of clinical and translational neuroscience. Highlights from the past 31 days include descriptions of a new technology that uses retinal scans to detect mild cognitive impairment, a white paper outlining challenges and opportunities for clinical trials in Alzheimer's disease, and genetic analyses that advance our understanding of the origins of Alzheimer’s disease.
While Dellila Hodgson’s primary duties involve overseeing experiments in the lab of Ornit Chiba-Falek, PhD, Hodgson considers herself a teacher at heart. So when Hodgson saw an opportunity to teach local middle school students about translational neuroscience through the Duke BOOST (Building Opportunities and Overtures in Science and Technology) program, she jumped at the chance.
A new blood-based test for Parkinson’s disease, improved monitoring techniques for epilepsy, and a chapter discussing the use of transcranial magnetic stimulation (TMS) as a noninvasive treatment for dystonia are just a few examples of the latest research from members of the Duke Neurology Department.
Local middle school students visited Duke this August to touch human brains, learn about the U.S. health system, and watch research being conducted in real time, thanks to the BOOST (Building Opportunities and Overtures in Science and Technology) program and the Duke Neurology Department.
About 60,000 babies are born before 32 weeks gestation in the United States every year, and 10% of them will develop cerebral palsy resulting from infections that damage nerve fibers deep in the brain called white matter.
While it’s known that the white matter loss will lead to neurological deficits, there is currently no treatment to help these infants avoid the outcome.
This July, members of the Duke Neurology Department contributed to 10 new peer-reviewed journal articles. Highlights of this research include a new study that found persistent associations between neighborhood income levels and poor outcomes for neurocritical care, a trio of studies that provide insights into the origins and development of Alzheimer’s disease, and a preliminary analysis of the merits of a potential off-label therapy for ALS.
A promising new therapy for brain tumors detailed in the New England Journal of Medicine and a validation of a popular stroke treatment for patients taking vitamin K antagonists published in JAMA are just two highlights of the 15 peer-reviewed journal articles authored by members of the Duke Neurology Department this June.